Publicaciones (202) Publicaciones de JESUS MARIA FERNANDEZ GOMEZ

2024

  1. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 4, pp. 618-626

2023

  1. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  2. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease

    Biomolecules, Vol. 13, Núm. 9

2022

  1. Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  3. Gene Expression Profile of Stromal Factors in Cancer-Associated Fibroblasts from Prostate Cancer

    Diagnostics, Vol. 12, Núm. 7

  4. Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment

    Cancers, Vol. 14, Núm. 18

2021

  1. Changes in the ambulatory care of prostate cancer patients during the SARS-CoV-2 pandemic. Literature review and contribution of our group in telematic care

    Actas Urologicas Espanolas, Vol. 45, Núm. 8, pp. 530-536

  2. Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)

    Actas Urologicas Espanolas, Vol. 45, Núm. 2, pp. 93-102

  3. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

    Scientific Reports, Vol. 11, Núm. 1

  4. Recommendations for antibiotic selection for severe nosocomial infections

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 511-524

2020

  1. Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry

    Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 156-163

  2. Clinical benefit of tamsulosin and the hexanic extract of serenoa repens, in combination or as monotherapy, in patients with moderate/severe luts-bph: A subset analysis of the qualiprost study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14

  3. Comparative analysis of the expression of metalloproteases (MMP-2, MMP-9, MMP-11 and MMP-13) and the tissue inhibitor of metalloprotease 3 (TIMP-3) between previous negative biopsies and radical prostatectomies

    Actas Urologicas Espanolas, Vol. 44, Núm. 2, pp. 78-85

2019

  1. Incidence of genitourinary pathology in the emergency department

    Archivos Espanoles de Urologia, Vol. 72, Núm. 4, pp. 389-397

  2. Usefulness of PET/CT 18-FDG for the diagnosis and follow-up of urological, urothelial and kidney tumours

    Actas Urologicas Espanolas, Vol. 43, Núm. 1, pp. 32-38

2018

  1. Actualización del papel de la quimioterapia endovesical en el cáncer de vejiga no músculo-invasivo

    Actas Urologicas Espanolas

  2. Clinical usefulness of random biopsies in diagnosis and treatment of non-muscle invasive bladder cancer: Systematic review and meta-analysis

    Actas Urologicas Espanolas

  3. Consolidation of ACTAS UROLÓGICAS ESPAÑOLAS

    Actas Urologicas Espanolas

  4. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies

    BJU International, Vol. 122, Núm. 6, pp. 1049-1065